BeyondSpring Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • BeyondSpring Pharmaceuticals
  • Dalian Wanchun Biotechnology
  • SEED Therapeutics
See more in Biomedtracker

Latest on BeyondSpring Inc.

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Asia Deal Watch: Ocumension Obtains Chinese Rights To Eight Alcon Products

 
• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. OcuMension Signs Stock-for-Rights

Scrip

Hengrui, BeyondSpring In Arbitration Face-Off After Cancer Deal Setbacks

 
• By Dexter Jie Yan

Jiangsu Hengrui Medicine Co., Ltd. is apparently going all-in to salvage a CNY200m ($27m) upfront payment it made to Dalian Wanchunbulin Pharmaceuticals, a China-based subsidiary of BeyondSpring Inc

Scrip

Opportunities Amid Crisis: Junshi, Allist Look To Expand Pipelines Through Alliances, M&A

 
• By Dexter Jie Yan

Two Chinese biopharma companies have recently aired their intentions to take stakes in or even acquire some of their peers in a bid to expand their pipelines, despite the ongoing general downturn in t